Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Drug Dissolution: Requirements and Profile Comparison01:14

Drug Dissolution: Requirements and Profile Comparison

The acceptance criteria for dissolution profile data are anchored in Q values, representing the percentage of drug dissolved within a specified period. This assessment unfolds in three stages:First Stage: The test passes if all six drug dosage units are equal to or greater than Q plus 5%; otherwise, the sample proceeds to the second stage.Second Stage: The average of twelve units must be equal to or greater than Q, with no unit falling below Q - 15% to pass; if not, it progresses to the final...
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Variable partition of non-homogeneous ooplasm sets the stage for divergent potency of 2-cell stage blastomeres.

Molecular human reproduction·2026
Same author

Integrative Multimodal Profiling of TAp73 and DNp73 Reveals Isoform-Specific Transcriptomic Coregulator Landscapes in Cancer Programs.

Biomolecules·2026
Same author

Multicondition expression profiling reveals limitations of canonical housekeeping genes.

BMC genomics·2026
Same author

A Digital Home-Based Health Care Center for Remote Monitoring of Side Effects During Breast Cancer Therapy: Prospective, Single-Arm, Monocentric Feasibility Study.

JMIR cancer·2025
Same author

Quantitative and qualitative Data on historical Vertebrate Distributions in Bavaria 1845.

Scientific data·2025
Same author

Animal and vegetal materials of mouse oocytes segregate at first zygotic cleavage: a simple mechanism that makes the two-cell blastomeres differ reciprocally from the start.

Molecular human reproduction·2025
Same journal

SA-MTP: a structure-aware framework for multifunctional therapeutic peptide annotation.

Briefings in bioinformatics·2026
Same journal

Genome assemblies and annotations are not static and need support for tracking their evolution.

Briefings in bioinformatics·2026
Same journal

A historical journey of metabolite-protein interaction discovery: from data harmonization to AI-driven prediction.

Briefings in bioinformatics·2026
Same journal

Bridging local-global transmembrane protein contexts with contrastive pretraining for alignment-free pathogenicity prediction.

Briefings in bioinformatics·2026
Same journal

Prediction of drug hypersensitivity by comprehensive modeling of HLA-peptidomes.

Briefings in bioinformatics·2026
Same journal

EssTFNet: integration of adaptive time-frequency and DNA language models for interpretable human essential gene prediction.

Briefings in bioinformatics·2026
See all related articles

Related Experiment Video

Updated: Jun 17, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

Scoring functions for drug-effect similarity.

Stephan Struckmann1,2, Mathias Ernst1,3, Sarah Fischer1

  • 1IBIMA, Rostock University Medical Center, Rostock, 18041, Germany.

Briefings in Bioinformatics
|June 3, 2020
PubMed
Summary
This summary is machine-generated.

Drug repurposing is challenging due to complex disease transcriptomes. This study proposes matching drug effects across different conditions, finding Pearson correlation reliable for identifying drugs and improving accuracy with gene filtering and network analysis.

Keywords:
drug repositioningdrug repurposingevaluationtranscriptomics

More Related Videos

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Related Experiment Videos

Last Updated: Jun 17, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Area of Science:

  • Computational biology
  • Pharmacogenomics
  • Drug discovery

Background:

  • Drug repurposing is crucial due to the high cost and time of developing new therapeutics.
  • Transcriptomic data from diseases and drug responses are complex and cell-specific, complicating direct matching.
  • Gene regulatory networks offer a potential common ground for linking disease and drug effects.

Purpose of the Study:

  • To develop and evaluate a method for matching drug effects to disease transcriptomes by comparing drug effects across different experimental conditions.
  • To identify reliable similarity scores and heuristics for predicting drug efficacy in drug repurposing.
  • To assess the impact of gene filtering and network-based approaches on prediction accuracy.

Main Methods:

  • Utilized the Connectivity Map (CMap) dataset, combining 26 similarity scores and six heuristics.
  • Implemented gene filtering based on expression levels and fold changes.
  • Applied network-based transcript reduction using FocusHeuristics.
  • Evaluated prediction accuracy using Pearson correlation and other metrics.

Main Results:

  • Pearson correlation demonstrated the highest reliability in identifying the same drug across different conditions.
  • Filtering for highly expressed genes significantly improved prediction accuracy.
  • Network-based transcript reduction and using landmark genes (1000) did not decrease prediction accuracy.
  • The proposed methods are reproducible and extendable with external data.

Conclusions:

  • Matching drug effects across different concentrations or cell lines is a viable strategy for drug repurposing.
  • Pearson correlation, combined with gene filtering and network analysis, provides a robust approach for predicting drug efficacy.
  • The developed methods and available source code can accelerate the discovery of new applications for existing drugs.